Trillium Therapeutics shares soar on Pfizer’s $2.26B deal

Trillium Therapeutics shares soar on Pfizer’s $2.26B deal


Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.

via DigioNews Markets

>>>MY ANOTHER SITE ONLINE MONEY FREE TECH : DROP99FAST

>>READ MORE : DIGIO NEWS

Note : I Hope My My New News Article : Trillium Therapeutics shares soar on Pfizer’s $2.26B deal Of DigioNews So You Trust My site you are always updated with Latest news Daily news Everyday. Only on DigioNews : Trillium Therapeutics shares soar on Pfizer’s $2.26B deal